Skip to main content
. 2018 Jan 1;8(4):1042–1058. doi: 10.7150/thno.22557

Figure 6.

Figure 6

(A) Blood retentions of OPCNs-PEG-FA in HepG2 tumor bearing mice during 48 h after intravenously injections; and (B) Biodistribution of OPCNs-PEG-FA in the major organs at 1 and 48 h post injections (n = 5), where α means OPCNs and β means OPCNs-PEG-FA.